Abstract
The duration of HT depends on balancing the presence of risk factors and the patient’s preferences. Some patients will want to continue indefinitely on HT. Others will want to get the most relief in the shortest amount of time possible.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Bibliography
LaCroix AZ, Chlebowski RT, Manson JE, et al. Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial. JAMA. 2011;305(13):1305–14.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Sherif, K. (2013). FAQ: Ending HT. In: Hormone Therapy. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6268-2_12
Download citation
DOI: https://doi.org/10.1007/978-1-4614-6268-2_12
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-6267-5
Online ISBN: 978-1-4614-6268-2
eBook Packages: MedicineMedicine (R0)